Dijon Stroke Cohort

Condition(s) studied

Investigational drug(s) / intervention(s)

Questionnaire and semi-structured interview: questionnaire submitted by telephone 3 months, 6 months, 1 year, 5 years, and 10 years after the stroke/TIA. interview duration 20 to 40 minutes

Study summary

The Dijon Stroke Registry, accredited by the Registry Evaluation Committee, INSERM and Public Health France, has been studying the epidemiology of cerebrovascular accidents (cerebral infarction, intracerebral haemorrhages, meningeal haemorrhages) and transient ischaemic attacks (TIAs) within the city of Dijon since 1985.

As a result of the development of therapies for acute disease, the prognosis of patients has improved over time. Thus, the number of stroke survivors has increased by 90% between the 1980s and today. This raises new issues: risk of vascular recurrence, drug iatrogeny, and functional impact of stroke for motor, cognitive or thymic function. In the absence of available data in France, the investigators wish to set up an extended cohort follow-up of patients in order to study their long-term prognosis and to study the impact of future therapies on the evolutionary course of the disease.

Eligibility

Primary outcome measure(s)

• Death rate — Trough study completion, an average of 10 years
• Disability rate — Trough study completion, an average of 10 years
• Quality of Life Questionnaire — Trough study completion, an average of 10 years
• Neuropsychological questionnaire — Trough study completion, an average of 10 years

Trial sites (1)

More Centre Hospitalier Universitaire Dijon trials in France